Current Report Filing (8-k)
May 24 2018 - 1:47PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): May 18, 2018
OCEAN
BIO-CHEM, INC
.
(Exact
name of registrant as specified in charter)
Florida
|
|
0-11102
|
|
59-1564329
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission File
Number)
|
|
I.R.S. Employer
Identification
No.)
|
4041
S.W. 47 Avenue, Fort Lauderdale, Florida 33314
(Address
of principal executive offices) (Zip Code)
(954)
587-6280
Registrant’s
telephone number, including area code:
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item
5.07. Submission of Matters to a Vote of Security Holders
Ocean
Bio-Chem, Inc. (the “Company”) held its Annual Meeting of Stockholders on May 18, 2018. The proposals submitted by
the Board of Directors to a vote of the shareholders, and the results of the voting on each proposal, are noted below.
Proposal
No. 1 — Election of Directors.
The
following nominees were elected by the shareholders to serve on the Company’s Board of Directors until the next annual meeting
of shareholders or until their respective successors have been duly elected and qualified:
Nominees
|
|
For
|
|
|
Withhold
|
|
|
Broker
Non-Votes
|
|
Jeffrey S. Barocas
|
|
|
6,621,606
|
|
|
|
307,941
|
|
|
|
2,263,031
|
|
Diana Mazuelos Conard
|
|
|
6,857,741
|
|
|
|
71,806
|
|
|
|
2,263,031
|
|
Gregor M. Dornau
|
|
|
6,671,074
|
|
|
|
258,473
|
|
|
|
2,263,031
|
|
Peter G. Dornau
|
|
|
6,671,074
|
|
|
|
258,473
|
|
|
|
2,263,031
|
|
William W. Dudman
|
|
|
6,671,074
|
|
|
|
258,473
|
|
|
|
2,263,031
|
|
James M. Kolisch
|
|
|
6,661,071
|
|
|
|
268,473
|
|
|
|
2,263,031
|
|
Kimberly A. Krause
|
|
|
6,867,741
|
|
|
|
61,806
|
|
|
|
2,263,031
|
|
John B. Turner
|
|
|
6,857,491
|
|
|
|
72,056
|
|
|
|
2,263,031
|
|
Proposal
No. 2 — Ratification of the Appointment of Independent Registered Public Accounting Firm.
The
shareholders ratified the appointment of Accell Audit & Compliance, PA as the Company's independent registered public accounting
firm for 2018. The voting results were as follows:
For
|
|
|
Against
|
|
|
Abstain
|
|
|
Broker Non-Votes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,031,643
|
|
|
|
-
|
|
|
|
-
|
|
|
|
2,263,031
|
|
Proposal
No. 3 — Advisory Vote on the Compensation of our Named Executive Officers;
The
shareholders approved, on an advisory basis, the compensation of our named executive officers. The voting results were as follows.
For
|
|
|
Against
|
|
|
Abstain
|
|
|
Broker Non-Votes
|
|
|
6,903,266
|
|
|
|
24,990
|
|
|
|
1,291
|
|
|
|
2,325,033
|
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
|
OCEAN BIO-CHEM, INC.
|
|
|
|
Date:
May 23, 2018
|
By:
|
/s/
Jeffrey S. Barocas
|
|
|
Jeffrey
S. Barocas
|
|
|
Chief
Financial Officer
|
2
Ocean Bio Chem (NASDAQ:OBCI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ocean Bio Chem (NASDAQ:OBCI)
Historical Stock Chart
From Apr 2023 to Apr 2024